- HKT Trust’s fiscal year net income was HK$5.07 billion, slightly below the estimated HK$5.16 billion.
- The company’s revenue reached HK$34.75 billion, narrowly missing the forecasted HK$34.82 billion.
- Total Solutions Services (TSS) contributed HK$24.46 billion to the revenue.
- EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) amounted to HK$13.74 billion, close to the expected HK$13.82 billion.
- Market analysts remain optimistic about HKT Trust with 5 buy recommendations, 0 hold, and 0 sell ratings.
A look at HKT Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, HKT Ltd shows a promising long-term outlook. With solid ratings in Dividend, Growth, and Momentum, the telecommunications company seems to be on a positive trajectory. A high score in Dividend suggests that HKT Ltd is committed to rewarding its investors, while strong Growth and Momentum scores indicate potential for future expansion and market performance. However, lower scores in Value and Resilience might warrant further consideration before making investment decisions.
HKT Ltd, part of HKT Trust, operates as a telecommunications provider offering a range of services including local telephony, data, broadband, and international telecommunications. Despite some mixed scores, the company’s overall outlook appears favorable, especially in terms of dividends, growth prospects, and market momentum. Investors looking for a telecom stock with growth potential and a focus on rewarding shareholders may find HKT Ltd an attractive investment option.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
